Prostate Cancer Treatment Choices
Authors: Andrew M.D. Wolf
Journal: Annals of Internal Medicine (2013)

LettersSeptember 17, 2013Prostate Cancer Treatment ChoicesAndrew M.D. Wolf, MDAndrew M.D. Wolf, MDFrom University of Virginia School of Medicine, Charlottesville, Virginia.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-159-6-201309170-00018 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Repetto and colleagues' editorial (1) inaccurately reports recommendation guidelines from the American Cancer Society, the American Urological Association, and the U.S. Preventive Services Task Force. Contrary to the authors' assertion, neither the American Cancer Society nor the American Urological Association recommends routine screening for prostate cancer. The American Cancer Society recommends that men be engaged in a shared decision-making process about whether they wish to be screened beginning at age 50 years for those at average risk, age 45 years for those at increased risk (African Americans or men with a history of prostate cancer in a ...References1. Repetto L, Abbatecola AM, and Paolisso G. “The older, the wiser” in prostate cancer treatment choices? [Editorial]. Ann Intern Med. 2013;158:772-3 LinkGoogle Scholar2. Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, et al. American Cancer Society Prostate Cancer Advisory Committee. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60:70-98. [PMID: 20200110] CrossrefMedlineGoogle Scholar3. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early Detection of Prostate Cancer: AUA Guideline. J Urol. 2013;190:419-26. [PMID: 23659877] CrossrefMedlineGoogle Scholar4. Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, et al. Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med. 2013;158:709-17 LinkGoogle Scholar5. Moyer VA; U. S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120-34 LinkGoogle Scholar Author, Article, and Disclosure InformationAuthors: Andrew M.D. Wolf, MDAffiliations: From University of Virginia School of Medicine, Charlottesville, Virginia.Disclosures: Other: Dr. Wolf was first author of the 2010 American Cancer Society Guideline for the Early Detection of Prostate Cancer. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee Also“The Older, the Wiser” in Prostate Cancer Treatment Choices? Lazzaro Repetto , Angela Marie Abbatecola , and Giuseppe Paolisso Prostate Cancer Treatment Choices Lazzaro M. Repetto , Angela Marie Abbatecola , and Giuseppe Paolisso Metrics September 17, 2013Volume 159, Issue 6Page: 435-436KeywordsAge groupsCancer screeningDecision makingHereditary nonpolyposis colorectal cancerLife expectancyProstate cancer ePublished: 17 September 2013 Issue Published: September 17, 2013 Copyright & PermissionsCopyright © 2013 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...